These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34544745)

  • 21. Doping in sport: a review of elite athletes' attitudes, beliefs, and knowledge.
    Morente-Sánchez J; Zabala M
    Sports Med; 2013 Jun; 43(6):395-411. PubMed ID: 23532595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of therapeutic use exemptions at the Olympic Games and Paralympic Games: an analysis of data from 2016 to 2022.
    Vernec A; Healy D; Banon T; Petroczi A
    Br J Sports Med; 2024 Sep; 58(17):966-972. PubMed ID: 38981660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Knowledge of pharmacy students about doping, and the need for doping education: a questionnaire survey.
    Shibata K; Ichikawa K; Kurata N
    BMC Res Notes; 2017 Aug; 10(1):396. PubMed ID: 28800770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doping control from a global and national perspective.
    Fraser AD
    Ther Drug Monit; 2004 Apr; 26(2):171-4. PubMed ID: 15228160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Identification of the role of the sports pharmacist with a model for the prediction of athletes' actions to cope with sickness].
    Yamaguchi T; Horio I; Aoki R; Yamashita N; Tanaka M; Izushi F; Miyauchi Y; Araki H
    Yakugaku Zasshi; 2013; 133(11):1249-59. PubMed ID: 24189566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
    Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
    Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Why Did the Sports Pharmacists Create the Card Game?].
    Shimizu M
    Yakugaku Zasshi; 2022; 142(2):115-121. PubMed ID: 35110446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Specialist pharmacist training from the viewpoint of sports pharmacology].
    Kasashi K
    Yakugaku Zasshi; 2012; 132(12):1325-8. PubMed ID: 23208035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Doping in disabled sports. Doping control activities at the Paralympic Games 1984-2008 and in Germany 1992-2008].
    Thevis M; Hemmersbach P; Geyer H; Schänzer W
    Med Klin (Munich); 2009 Dec; 104(12):918-24. PubMed ID: 20039158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing anti-doping knowledge among Taiwanese pharmacists.
    Lee YC; Chen CY; Cheng YY; Hsu MC; Chen TT; Chang WC
    BMC Med Educ; 2023 Oct; 23(1):808. PubMed ID: 37891558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doping control in sports--a perspective from the 1996 Olympic Games.
    Ambrose PJ
    Am J Health Syst Pharm; 1997 May; 54(9):1053-7. PubMed ID: 9143653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug use in sports: a veritable arena for pharmacists.
    Ambrose PJ
    J Am Pharm Assoc (2003); 2004; 44(4):501-14; quiz 514-6. PubMed ID: 15372871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The athletic characteristics of Olympic sports to assist anti-doping strategies.
    Hayward G; Gaborini L; Sims D; Schumacher YO; Millet GP; Rhumorbarbe D; Coquet R; Robinson N
    Drug Test Anal; 2022 Sep; 14(9):1599-1613. PubMed ID: 35732071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Anti-doping reference for pharmacists].
    Kasashi K
    Yakugaku Zasshi; 2009 Dec; 129(12):1475-81. PubMed ID: 19952525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Moral Foundation for Anti-Doping: How Far Have We Progressed? Where Are the Limits?
    Murray TH
    Med Sport Sci; 2017; 62():186-193. PubMed ID: 28571014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rebooting a sports pharmacy advanced pharmacy practice experience: Utilizing medicinal chemistry as a foundational approach to get pharmacists back in the game.
    DellaVecchia MJ; Marrero RJ; James JL; Vanscoy TD; Lendoiro JE
    Curr Pharm Teach Learn; 2020 Aug; 12(8):981-1003. PubMed ID: 32565001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current situation and measures to promote anti-doping activities in Japan].
    Asakawa S
    Yakugaku Zasshi; 2011; 131(12):1755-6. PubMed ID: 22129872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidoping in paralympic sport.
    Van de Vliet P
    Clin J Sport Med; 2012 Jan; 22(1):21-5. PubMed ID: 22222592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood doping at the Olympic Games.
    Fitch KD
    J Sports Med Phys Fitness; 2017 Nov; 57(11):1526-1532. PubMed ID: 28094487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. University-based sports pharmacy program.
    Price KO; Huff PS; Isetts BJ; Goldwire MA
    Am J Health Syst Pharm; 1995 Feb; 52(3):302-9. PubMed ID: 7749959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.